SCHEMBL24718655

SCHEMBL24718655

Cc1ccc(O)c(C(=O)NC2CC(=O)N(Cc3ccccc3C(=O)O)C2)c1

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ BRD4 O60885 6/20 0.42
▸ CSNK2A1 P68400 1/20 0.40
▸ GAA P10253 2/20 0.39
▸ MEN1 O00255 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ TP53 P04637 2/20 0.39
▸ ACSS2 Q9NR19 1/20 0.38
▸ SIRT1 Q96EB6 1/20 0.38
▸ LMNA P02545 2/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ RAB9A P51151 1/20 0.38
▸ POLB P06746 2/20 0.37
▸ MAPK1 P28482 1/20 0.37
▸ HTT P42858 1/20 0.37
▸ LIPG Q9Y5X9 1/20 0.37
▸ TAS1R3 Q7RTX0 1/20 0.37
▸ TAS1R1 Q7RTX1 1/20 0.37
▸ TAS1R2 Q8TE23 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24718425 0.90 SIRT1 (0.43) BRD4GAAMEN1KMT2AALDH1A1
SCHEMBL24718283 0.88 MEN1 (0.45) GAAMEN1KMT2AALDH1A1LMNA
SCHEMBL24718415 0.86 TP53 (0.49) GAAMEN1KMT2AALDH1A1TP53
SCHEMBL24718290 0.79 TSHR (0.45) MEN1KMT2AALDH1A1POLBMAPK1
SCHEMBL24718644 0.79 ALDH1A1 (0.42) BRD4GAAMEN1KMT2AALDH1A1
SCHEMBL24719112 0.78 SMN1; SMN2 (0.44) GAAMEN1KMT2AALDH1A1LMNA
SCHEMBL24718657 0.78 SMN1; SMN2 (0.44) GAAMEN1KMT2AALDH1A1LMNA
SCHEMBL24719133 0.78 SMN1; SMN2 (0.44) GAAMEN1KMT2AALDH1A1LMNA
SCHEMBL24718838 0.78 TP53 (0.49) GAAMEN1KMT2AALDH1A1TP53
SCHEMBL24718430 0.78 P2RX1 (0.45) GAAMEN1KMT2AALDH1A1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220363633-A1 SUBSTITUTED PYRROLIDONES AND PIPERIDONES AS SMALL MOLECULE INHIBITORS OF EZH2 AND EED PROTEIN BINDING UNITED STATES GOVERNMENT 2022-11-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220363633-A1 SUBSTITUTED PYRROLIDONES AND PIPERIDONES AS SMALL MOLECULE INHIBITORS OF EZH2 AND EED PROTEIN BINDING EED, EZH2, ELP1 BRD4 82/4885CSNK2A1 2337/4885GAA 4271/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback